These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 16581092

  • 1. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA, Hughes ZA, Starr KR, Storey JD, Bettelini L, Bacchi F, Arban R, Poffe A, Melotto S, Hagan JJ, Price GW.
    Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
    [Abstract] [Full Text] [Related]

  • 2. SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.
    Scott C, Langmead CJ, Clarke KL, Wyman P, Smith PW, Starr KR, Dawson LA, Price GW, Hagan JJ, Watson J.
    Neuropharmacology; 2006 Jun; 50(8):984-90. PubMed ID: 16546225
    [Abstract] [Full Text] [Related]

  • 3. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
    Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E.
    J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
    [Abstract] [Full Text] [Related]

  • 4. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM, Blaney FE, Davies S, Duckworth DM, Ham P, Jenkins S, Jennings AJ, Joiner GF, King FD, Mulholland KR, Wyman PA, Hagan JJ, Hatcher J, Jones BJ, Middlemiss DN, Price GW, Riley G, Roberts C, Routledge C, Selkirk J, Slade PD.
    J Med Chem; 1998 Apr 09; 41(8):1218-35. PubMed ID: 9548813
    [Abstract] [Full Text] [Related]

  • 5. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A, Nikiforuk A.
    Neuropharmacology; 2007 Apr 09; 52(5):1274-83. PubMed ID: 17320917
    [Abstract] [Full Text] [Related]

  • 6. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
    Wesołowska A, Nikiforuk A, Stachowicz K.
    Behav Pharmacol; 2007 Sep 09; 18(5-6):439-46. PubMed ID: 17762512
    [Abstract] [Full Text] [Related]

  • 7. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A, Kulkarni SK.
    Brain Res Bull; 2007 Sep 14; 74(1-3):58-65. PubMed ID: 17683790
    [Abstract] [Full Text] [Related]

  • 8. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D, Leggio GM, Mazzola C, Micale V, Drago F.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):139-47. PubMed ID: 17669397
    [Abstract] [Full Text] [Related]

  • 9. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK, Dhir A.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):163-72. PubMed ID: 18585703
    [Abstract] [Full Text] [Related]

  • 10. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S, Hirota S, Funakoshi T, Suzuki Y, Suetake S, Okubo T, Ishii T, Nakazato A, Okuyama S.
    J Pharmacol Exp Ther; 2003 Feb 28; 304(2):818-26. PubMed ID: 12538838
    [Abstract] [Full Text] [Related]

  • 11. Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectra.
    Kantor S, Jakus R, Molnar E, Gyongyosi N, Toth A, Detari L, Bagdy G.
    J Pharmacol Exp Ther; 2005 Nov 28; 315(2):921-30. PubMed ID: 16085759
    [Abstract] [Full Text] [Related]

  • 12. Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.
    Kassai F, Schlumberger C, Kedves R, Pietraszek M, Jatzke C, Lendvai B, Gyertyán I, Danysz W.
    Behav Pharmacol; 2012 Aug 28; 23(4):397-406. PubMed ID: 22785385
    [Abstract] [Full Text] [Related]

  • 13. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
    Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2002 Aug 28; 54(6):615-23. PubMed ID: 12866716
    [Abstract] [Full Text] [Related]

  • 14. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
    Rajarao SJ, Platt B, Sukoff SJ, Lin Q, Bender CN, Nieuwenhuijsen BW, Ring RH, Schechter LE, Rosenzweig-Lipson S, Beyer CE.
    Neuropeptides; 2007 Oct 28; 41(5):307-20. PubMed ID: 17637475
    [Abstract] [Full Text] [Related]

  • 15. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
    Dekeyne A, Brocco M, Loiseau F, Gobert A, Rivet JM, Di Cara B, Cremers TI, Flik G, Fone KC, Watson DJ, Papp M, Sharp T, Serres F, Cespuglio R, Olivier B, Chan JS, Lavielle G, Millan MJ.
    J Pharmacol Exp Ther; 2012 Mar 28; 340(3):765-80. PubMed ID: 22178753
    [Abstract] [Full Text] [Related]

  • 16. In vivo/ex vivo and behavioural study on central effects of 5-HT1B/1D and 5-HT1A antagonists in guinea pigs.
    Rex A, Voigt JP, Wicke KM, Fink H.
    Pharmacol Biochem Behav; 2008 Jan 28; 88(3):196-204. PubMed ID: 17888505
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system.
    Freitas AE, Budni J, Lobato KR, Binfaré RW, Machado DG, Jacinto J, Veronezi PO, Pizzolatti MG, Rodrigues AL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar 17; 34(2):335-43. PubMed ID: 20026371
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of 5-HT1B receptors causes hypothermia in the guinea pig.
    Hagan JJ, Slade PD, Gaster L, Jeffrey P, Hatcher JP, Middlemiss DN.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):169-74. PubMed ID: 9274976
    [Abstract] [Full Text] [Related]

  • 19. Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
    Jesse CR, Wilhelm EA, Bortolatto CF, Nogueira CW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar 17; 34(2):294-302. PubMed ID: 19961893
    [Abstract] [Full Text] [Related]

  • 20. Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action.
    Tatarczyńska E, Antkiewicz-Michaluk L, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.
    Eur J Pharmacol; 2005 May 23; 516(1):46-50. PubMed ID: 15913599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.